» Articles » PMID: 32913051

Early Programming of CD8 T Cell Response by the Orphan Nuclear Receptor NR4A3

Overview
Specialty Science
Date 2020 Sep 11
PMID 32913051
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Enhancing long-term persistence while simultaneously potentiating the effector response of CD8 T cells has been a long-standing goal in immunology to produce better vaccines and adoptive cell therapy products. NR4A3 is a transcription factor of the orphan nuclear receptor family. While it is rapidly and transiently expressed following T cell activation, its role in the early stages of T cell response is unknown. We show that NR4A3-deficient murine CD8 T cells differentiate preferentially into memory precursor and central memory cells, but also produce more cytokines. This is explained by an early influence of NR4A3 deficiency on the memory transcriptional program and on accessibility of chromatin regions with motifs for bZIP transcription factors, which impacts the transcription of Fos/Jun target genes. Our results reveal a unique and early role for NR4A3 in programming CD8 T cell differentiation and function. Manipulating NR4A3 activity may represent a promising strategy to improve vaccination and T cell therapy.

Citing Articles

AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol.

Jin L, Li J, Zhu F Hum Vaccin Immunother. 2024; 20(1):2426319.

PMID: 39569615 PMC: 11583616. DOI: 10.1080/21645515.2024.2426319.


Transcriptional rewiring in CD8 T cells: implications for CAR-T cell therapy against solid tumours.

Srinivasan S, Armitage J, Nilsson J, Waithman J Front Immunol. 2024; 15:1412731.

PMID: 39399500 PMC: 11466849. DOI: 10.3389/fimmu.2024.1412731.


NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors.

Nakagawara K, Ando M, Srirat T, Mise-Omata S, Hayakawa T, Ito M J Immunother Cancer. 2024; 12(8).

PMID: 39151930 PMC: 11331892. DOI: 10.1136/jitc-2023-008665.


A pan-cancer analysis unveiling the function of NR4A family genes in tumor immune microenvironment, prognosis, and drug response.

Park S, Han M Genes Genomics. 2024; 46(8):977-990.

PMID: 38976216 DOI: 10.1007/s13258-024-01539-1.


Potential Roles of Nr4a3-Mediated Inflammation in Immunological and Neurological Diseases.

He S, Jiang W, Jiang B, Yu C, Zhao G, Li Y Mol Neurobiol. 2024; 61(8):5958-5973.

PMID: 38261254 DOI: 10.1007/s12035-024-03945-8.


References
1.
Fassett M, Jiang W, DAlise A, Mathis D, Benoist C . Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc Natl Acad Sci U S A. 2012; 109(10):3891-6. PMC: 3309794. DOI: 10.1073/pnas.1200090109. View

2.
Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, Zinkernagel R . Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods. 1991; 33(1-2):191-8. DOI: 10.1016/0166-0934(91)90018-u. View

3.
Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

4.
Roychoudhuri R, Clever D, Li P, Wakabayashi Y, Quinn K, Klebanoff C . BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers. Nat Immunol. 2016; 17(7):851-860. PMC: 4918801. DOI: 10.1038/ni.3441. View

5.
Chou C, Pinto A, Curtis J, Persaud S, Cella M, Lin C . c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat Immunol. 2014; 15(9):884-93. PMC: 4139462. DOI: 10.1038/ni.2943. View